Flyer

Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Lyell Syndrome: Complexity Management in a Medical Ward

XX Congresso Regionale FADOI CAMPANIA: Non ci siamo mai fermati
Italy 2021

Ciampa C, Fabozzi G, Esposito S, Ricciardi R, Giugliano C, Renis M*, Gentile M, Grieco L, Del Gatto A,  

Scuola di Specializzazione in Medicina Interna UNISA, Italy
Scuola di Specializzazone in Farmacologia e Tossicologia Clinica UNISA, Italy
Medicina Interna P.O Cava AOU �?¢�?�?�?�?San Giovanni di Dio e Ruggi d�?¢�?�?�?�?Aragona�?¢�?�?�? Salerno, Italy
Clinica Medica ed Epatologia AOU �?¢�?�?�?�?San Giovanni di Dio e Ruggi d�?¢�?�?�?�?Aragona�?¢�?�?�? Salerno, Italy

Posters & Accepted Abstracts: Health Sci J

Abstract:

Background: Lyell Syndrome is a rare disease (incidence 1/100000, lethality rate: 70%) characterized by extensive epidermal necrosis. Case report: Female, 75 y.o. In E.R. for dehydration, confusion, and extensive necrotic mucocutaneous lesions. History: advanced stage intestinal cancer; recently undergone ceftriaxone 1 g/day for 15 days, for urinary infection. Dermatological valuation: suspected Lyell Syndrome, probably iatrogenic, involving about 80% skin. Admitted to our Medical Ward (no availability in Intensive Department). She was not transferred to a Burn Ward, due to her frailty, comorbidities, and extremely compromised clinical conditions. The patient, isolated, underwent a skin swab and skin biopsy, which confirmed the diagnostic hypothesis. Treatment: Rehydrating Solution: 3500 ml/day, Parenteral Nutrition, Albumin 25% 50 ml: 3 FLC/ day, Immunoglobulins: 0.4 g/kg/day for five days, Tigecycline 50 mg twice/day (St. Haemolyticus positivity), high dose Methylprednisolone: 60 mg/kg/day (with gradual reduction), advanced dressings of skin lesions in a sterile environment. The patient was eventually discharged with no active skin lesions and negative skin swabs. Discussion: This case shows, in our opinion, how, thanks to adequate staff training, it is possible to create complex organizational settings in order to treat patients who need high intensity of care, in medical wards rather than in intensive care.